المؤلفون: Gupta N; Department of Materials Science and Engineering, Indian Institute of Technology Delhi, New Delhi, Hauz Khas 110016, India.; Department of Applied Chemistry, National Yang-Ming Chiao Tung University, Hsinchu 30010, Taiwan.; International College of Semiconductor Technology, National Yang-Ming Chiao Tung University, Hsinchu 30010, Taiwan., Sharma PK; Delhi Institute of Pharmaceutical Science and Research, Delhi Pharmaceutical Sciences and Research University, Pushp Vihar S3, New Delhi 110017, India., Yadav SS; Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Raebareli, Uttar Pradesh 226002, India., Chauhan M; Delhi Institute of Pharmaceutical Science and Research, Delhi Pharmaceutical Sciences and Research University, Pushp Vihar S3, New Delhi 110017, India., Datusalia AK; Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Raebareli, Uttar Pradesh 226002, India., Saha S; Department of Materials Science and Engineering, Indian Institute of Technology Delhi, New Delhi, Hauz Khas 110016, India.

المصدر: ACS biomaterials science & engineering [ACS Biomater Sci Eng] 2024 Aug 12; Vol. 10 (8), pp. 5039-5056. Date of Electronic Publication: 2024 Jul 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101654670 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2373-9878 (Electronic) Linking ISSN: 23739878 NLM ISO Abbreviation: ACS Biomater Sci Eng Subsets: MEDLINE

مواضيع طبية MeSH: Carbidopa*/pharmacokinetics , Carbidopa*/administration & dosage , Carbidopa*/therapeutic use , Carbidopa*/pharmacology , Levodopa*/pharmacokinetics , Levodopa*/administration & dosage , Levodopa*/therapeutic use , Levodopa*/pharmacology , Parkinson Disease*/drug therapy , Delayed-Action Preparations*/chemistry , Catechols*/chemistry , Catechols*/therapeutic use , Catechols*/pharmacology , Catechols*/pharmacokinetics , Drug Carriers*/chemistry, Animals ; Rats ; Male ; Nitriles/pharmacokinetics ; Nitriles/therapeutic use ; Nitriles/pharmacology ; Antiparkinson Agents/pharmacokinetics ; Antiparkinson Agents/therapeutic use ; Antiparkinson Agents/administration & dosage ; Antiparkinson Agents/pharmacology ; Drug Liberation ; Rats, Sprague-Dawley ; Rotenone/pharmacology

المؤلفون: Dean MN; Department of Neurology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Standaert DG

المصدر: Current opinion in neurology [Curr Opin Neurol] 2024 Aug 01; Vol. 37 (4), pp. 409-413. Date of Electronic Publication: 2024 May 23.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9319162 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-6551 (Electronic) Linking ISSN: 13507540 NLM ISO Abbreviation: Curr Opin Neurol Subsets: MEDLINE

مواضيع طبية MeSH: Levodopa*/administration & dosage , Levodopa*/therapeutic use , Parkinson Disease*/drug therapy , Antiparkinson Agents*/administration & dosage , Antiparkinson Agents*/therapeutic use , Carbidopa*/administration & dosage , Carbidopa*/therapeutic use, Humans ; Drug Combinations ; Infusions, Subcutaneous/methods

المؤلفون: Yuksel JM; 1 Upstate Community Hospital, 4900 Broad Road, Syracuse, New York., Ulen KR; 1 Upstate Community Hospital, 4900 Broad Road, Syracuse, New York., Brenner JM; 1 Upstate Community Hospital, 4900 Broad Road, Syracuse, New York., Brangman SA; 2 Upstate University Hospital, 750 East Adam Street, Syracuse, New York., Noviasky J; 1 Upstate Community Hospital, 4900 Broad Road, Syracuse, New York.

المصدر: The Senior care pharmacist [Sr Care Pharm] 2024 Jul 01; Vol. 39 (7), pp. 242-248.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Consultant Pharmacists Country of Publication: United States NLM ID: 101737969 Publication Model: Print Cited Medium: Print ISSN: 2639-9636 (Print) Linking ISSN: 26399636 NLM ISO Abbreviation: Sr Care Pharm Subsets: MEDLINE

مواضيع طبية MeSH: Carbidopa*/administration & dosage , Carbidopa*/therapeutic use , Levodopa*/administration & dosage , Levodopa*/therapeutic use , Parkinson Disease*/drug therapy , Emergency Service, Hospital*/statistics & numerical data , Drug Combinations* , Length of Stay* , Antiparkinson Agents*/administration & dosage , Antiparkinson Agents*/therapeutic use, Humans ; Aged ; Male ; Female ; Retrospective Studies ; Aged, 80 and over ; Treatment Outcome ; Patient Readmission/statistics & numerical data

المؤلفون: Chaudhuri KR; Parkinson's Foundation International Centre of Excellence, King's College Hospital, London, UK.; King's College Institute of Psychiatry, Psychology & Neuroscience, London, UK., Facheris MF; AbbVie Inc., North Chicago, Illinois, USA., Bergmans B; Department of Neurology, AZ St-Jan Brugge-Oostende AV, Bruges, Belgium.; Department of Neurology, Ghent University Hospital, Ghent, Belgium., Bergquist F; Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Pharmacology, University of Gothenburg, Gothenburg, Sweden., Criswell SR; Muhammad Ali Parkinson Center, Barrow Neurologic Institute, Phoenix, Arizona, USA., Jia J; AbbVie Inc., North Chicago, Illinois, USA., Kukreja P; AbbVie Inc., North Chicago, Illinois, USA., Mukai Y; Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan., Spiegel AM; AbbVie Inc., North Chicago, Illinois, USA., Gupta R; AbbVie Inc., North Chicago, Illinois, USA., Bergmann L; AbbVie Inc., North Chicago, Illinois, USA., Pahwa R; Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA.

المصدر: Movement disorders clinical practice [Mov Disord Clin Pract] 2024 Jul; Vol. 11 (7), pp. 861-866. Date of Electronic Publication: 2024 Mar 11.

نوع المنشور: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101630279 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2330-1619 (Electronic) Linking ISSN: 23301619 NLM ISO Abbreviation: Mov Disord Clin Pract Subsets: MEDLINE

مواضيع طبية MeSH: Quality of Life* , Carbidopa*/administration & dosage , Carbidopa*/therapeutic use , Levodopa*/administration & dosage , Levodopa*/therapeutic use , Drug Combinations* , Parkinson Disease*/drug therapy , Antiparkinson Agents*/administration & dosage , Antiparkinson Agents*/therapeutic use , Sleep*/drug effects, Humans ; Male ; Female ; Middle Aged ; Aged ; Treatment Outcome ; Double-Blind Method ; Activities of Daily Living

المؤلفون: Wang S; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China., Jiang Y; Department of Functional Neurosurgery, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China; Beijing Key Laboratory of Neurostimulation, Beijing, China., Yang A; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China., Meng F; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China; Department of Functional Neurosurgery, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China; Beijing Key Laboratory of Neurostimulation, Beijing, China., Zhang J; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China; Department of Functional Neurosurgery, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China; Beijing Key Laboratory of Neurostimulation, Beijing, China. Electronic address: jianguozhang@ccmu.edu.cn.

المصدر: The Lancet. Neurology [Lancet Neurol] 2024 Sep; Vol. 23 (9), pp. 856.

نوع المنشور: Letter

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 101139309 Publication Model: Print Cited Medium: Internet ISSN: 1474-4465 (Electronic) Linking ISSN: 14744422 NLM ISO Abbreviation: Lancet Neurol Subsets: MEDLINE

مواضيع طبية MeSH: Levodopa*/administration & dosage , Parkinson Disease*/drug therapy , Carbidopa*/administration & dosage , Antiparkinson Agents*/administration & dosage , Infusions, Subcutaneous* , Drug Combinations*, Humans

المؤلفون: Espay AJ; James J and Joan A Gardner Center for Parkinson's Disease and Movement Disorders, University of Cincinnati, Cincinnati, OH 45219, USA. Electronic address: alberto.espay@uc.edu., Rascol O; University of Toulouse 3, University Hospital of Toulouse, INSERM, Clinical Investigation Center CIC1436, Department of Neurosciences and Department of Clinical Pharmacology, Toulouse, France; NS-Park/FCRIN Network, Toulouse, France.

المصدر: The Lancet. Neurology [Lancet Neurol] 2024 Sep; Vol. 23 (9), pp. 857.

نوع المنشور: Letter; Comment

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 101139309 Publication Model: Print Cited Medium: Internet ISSN: 1474-4465 (Electronic) Linking ISSN: 14744422 NLM ISO Abbreviation: Lancet Neurol Subsets: MEDLINE

مواضيع طبية MeSH: Levodopa*/administration & dosage , Parkinson Disease*/drug therapy , Carbidopa*/administration & dosage , Antiparkinson Agents*/administration & dosage , Infusions, Subcutaneous*, Humans ; Drug Combinations

المؤلفون: Moes HR; Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen 9713 GZ, Netherlands. Electronic address: h.r.moes@umcg.nl., Buskens E; Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen 9713 GZ, Netherlands., van Laar T; Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen 9713 GZ, Netherlands.

المصدر: The Lancet. Neurology [Lancet Neurol] 2024 Sep; Vol. 23 (9), pp. 856-857.

نوع المنشور: Letter

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 101139309 Publication Model: Print Cited Medium: Internet ISSN: 1474-4465 (Electronic) Linking ISSN: 14744422 NLM ISO Abbreviation: Lancet Neurol Subsets: MEDLINE

مواضيع طبية MeSH: Levodopa*/administration & dosage , Parkinson Disease*/drug therapy , Carbidopa*/administration & dosage , Antiparkinson Agents*/administration & dosage , Infusions, Subcutaneous* , Drug Combinations*, Humans

المؤلفون: Miyaue N; Department of Clinical Pharmacology and Therapeutics, Ehime University Graduate School of Medicine, Toon, Ehime, Japan; Department of Neurology, Saiseikai Matsuyama Hospital, Matsuyama, Ehime, Japan. Electronic address: miyaue@m.ehime-u.ac.jp., Yabe H; Department of Neurology, Saiseikai Matsuyama Hospital, Matsuyama, Ehime, Japan., Nagai M; Department of Clinical Pharmacology and Therapeutics, Ehime University Graduate School of Medicine, Toon, Ehime, Japan.

المصدر: Journal of the neurological sciences [J Neurol Sci] 2024 Oct 15; Vol. 465, pp. 123202. Date of Electronic Publication: 2024 Aug 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0375403 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-5883 (Electronic) Linking ISSN: 0022510X NLM ISO Abbreviation: J Neurol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Levodopa*/pharmacokinetics , Levodopa*/administration & dosage , Levodopa*/blood , Esomeprazole*/administration & dosage , Esomeprazole*/pharmacokinetics , Parkinson Disease*/drug therapy , Parkinson Disease*/blood , Antiparkinson Agents*/pharmacokinetics , Antiparkinson Agents*/administration & dosage , Antiparkinson Agents*/blood , Proton Pump Inhibitors*/administration & dosage , Proton Pump Inhibitors*/pharmacokinetics , Carbidopa*/pharmacokinetics , Carbidopa*/administration & dosage , Drug Interactions*, Humans ; Male ; Female ; Aged ; Middle Aged ; Prospective Studies

المؤلفون: Frequin HL; Department of Neurology, Amsterdam University Medical Centers, Amsterdam Neuroscience, Amsterdam, the Netherlands., Verschuur CVM; Department of Neurology, Amsterdam University Medical Centers, Amsterdam Neuroscience, Amsterdam, the Netherlands., Suwijn SR; Department of Neurology, Amsterdam University Medical Centers, Amsterdam Neuroscience, Amsterdam, the Netherlands., Boel JA; Department of Medical Psychology, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Post B; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behavior, Center of Expertise for Parkinson & Movement Disorders, Nijmegen, the Netherlands., Bloem BR; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behavior, Center of Expertise for Parkinson & Movement Disorders, Nijmegen, the Netherlands., van Hilten JJ; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands., van Laar T; Department of Neurology, University Medical Center Groningen, Groningen, the Netherlands., Tissingh G; Department of Neurology, Zuyderland Medical Center, Heerlen, the Netherlands., Munts AG; Department of Neurology, Excellent Klinieken, Dordrecht, the Netherlands., Dijk JM; Department of Neurology, Amsterdam University Medical Centers, Amsterdam Neuroscience, Amsterdam, the Netherlands., Lang AE; The Edmond J. Safra Program in Parkinson's Disease and Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada., Dijkgraaf MGW; Department of Epidemiology and Data Science, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Hoogland J; Department of Epidemiology and Data Science, Amsterdam University Medical Centers, Amsterdam, the Netherlands., de Bie RMA; Department of Neurology, Amsterdam University Medical Centers, Amsterdam Neuroscience, Amsterdam, the Netherlands.

مؤلفون مشاركون: LEAP Study Group

المصدر: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2024 Jun; Vol. 39 (6), pp. 975-982. Date of Electronic Publication: 2024 Apr 21.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8610688 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-8257 (Electronic) Linking ISSN: 08853185 NLM ISO Abbreviation: Mov Disord Subsets: MEDLINE

مواضيع طبية MeSH: Levodopa*/administration & dosage , Levodopa*/adverse effects , Levodopa*/therapeutic use , Parkinson Disease*/drug therapy , Antiparkinson Agents*/administration & dosage , Antiparkinson Agents*/adverse effects , Antiparkinson Agents*/therapeutic use , Carbidopa*/administration & dosage , Carbidopa*/adverse effects, Humans ; Male ; Female ; Middle Aged ; Aged ; Follow-Up Studies ; Disease Progression ; Treatment Outcome ; Double-Blind Method ; Drug Combinations ; Severity of Illness Index ; Time Factors

المؤلفون: Anjani QK; School of Pharmacy, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL, UK; Fakultas Farmasi, Universitas Megarezky, Jl. Antang Raya No. 43, Makassar 90234, Indonesia., Moreno-Castellanos N; Basic Science Department, Faculty of Health, Universidad Industrial de Santander, Bucaramanga 680001, Colombia., Li Y; School of Pharmacy, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL, UK., Sabri AHB; School of Pharmacy, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL, UK., Donnelly RF; School of Pharmacy, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL, UK. Electronic address: r.donnelly@qub.ac.uk.

المصدر: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2024 Jun; Vol. 199, pp. 114304. Date of Electronic Publication: 2024 Apr 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 9109778 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3441 (Electronic) Linking ISSN: 09396411 NLM ISO Abbreviation: Eur J Pharm Biopharm Subsets: MEDLINE

مواضيع طبية MeSH: Carbidopa*/administration & dosage , Levodopa*/administration & dosage , Parkinson Disease*/drug therapy , Administration, Cutaneous* , Antiparkinson Agents*/administration & dosage , Antiparkinson Agents*/pharmacology, Animals ; Swine ; Humans ; Transdermal Patch ; Skin/metabolism ; Skin/drug effects ; Drug Delivery Systems/methods ; Fibroblasts/drug effects ; Fibroblasts/metabolism ; Skin Absorption/drug effects ; Drug Combinations